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Introduction
Reversible inactivations of small volumes of brain tissue have been used to explore fundamental questions in behavioral and systems neuroscience (Majchrzak and Di Scala, 2000) .
Reversible inactivations are an important alternative to permanent brain lesions (Jarrard, 2002) in assessing structure-function relationships. The obvious advantage is that reversible brain inactivations allow within-subjects designs. One common disadvantage is that this method typically leaves considerable uncertainty about the size and shape of the volume of the druginfused tissue.
Muscimol, a GABA A -agonist (Beaumont et al., 1978) , is commonly and productively used for reversible inactivations (Lomber, 1999; Martin and Ghez, 1999; Krupa and Thompson, 1997) . However, the spatial extent of a muscimol infusion is indeterminate without the use a radioactive tracer ([ 3 H]muscimol; Martin, 1991; Edeline et al., 2002) . Indirect estimates about the spread of muscimol have been obtained by measuring its anticipated functional consequences on glucose uptake (Martin, 1991) , evoked field potentials (Wilensky et al., 2006) , and multiunit activity levels (Arikan et al., 2002; Edeline et al., 2002) . Practical considerations have precluded the routine use of either radioactive or functional techniques (but see Krupa and Thompson, 1997 ).
Here we evaluated the use of a fluorophore-conjugated muscimol molecule (FCM) for producing local and reversible brain inactivations. FCM was first used in conjunction with muscimol to assess the role of dorsomedial prefrontal cortex (dmPFC) in a delayed-response task . Here, the evaluation of FCM made use of whole-cell recordings, well-characterized brain-behavior relationships, and optical
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Materials and Methods

Subjects.
This study used a total of 15 rats, described for each experiment below.
Procedures were approved by the Yale University Animal Care and Use Committees (whole-cell, acute infusion, and fear conditioning) and the John B. Pierce Laboratory (delayed-response task).
Drugs.
Muscimol was acquired from Sigma-Aldrich. FCM (commercially designated as Muscimol-TMR-X) was acquired from Molecular Probes (product #M23400, www.molecularprobes.com). FCM is a conjugate of muscimol and the Bodipy® TMR-X fluorophore (covalent amide bonding). FCM is stable and will not dissociate into its constituent parts in solution. The Bodipy® TMR-X portion of FCM is highly lipophilic (personal communication, Molecular Probes, Technical Support, Carlsbad, CA). FCM has excitation and emission peaks, respectively, at 543 nm and 572 nm. Figure 1 shows the structures, formulas, and molecular weights of FCM and muscimol.
For both acute infusions and fear conditioning experiments, 1 mg of FCM was dissolved into 2 mL of 0.01 M phosphate buffered 0.9% saline (PBS), resulting in a 0.8 mM concentration.
For the brain-slice experiments, this stock solution was then diluted in artificial cerebral spinal fluid (aCFS) to a final bath concentration of 10 M. For the delayed-response experiments, 1 mg FCM was dissolved in 1 mL of 0.9% saline, resulting in a 1.6 mM concentration. FCM concentrations higher than 1 mg/ml are possible, using dimethyl sulfoxide (DMSO) as a solvent, but were not explored here. A c c e p t e d M a n u s c r i p t
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Whole-Cell
Recordings. Whole-cell recordings were performed in horizontal brain slices that included the medial temporal lobe. The methods have been described in extensive detail elsewhere (Faulkner and Brown, 1999; Moyer and Brown, 1998; 2002; Individual slices were transferred to a submerged-type recording chamber and perfused with oxygenated aCSF. Recordings were done at room temperature. PR was visualized using an upright microscope (Zeiss Axioskop) equipped with infrared-filtered light and differential interference contrast optics. A bipolar stimulating electrode was positioned into layer I of PR.
The whole-cell recording pipette (3 -5 MΩ) was directed to layer V of PR. The pipette solution contained (in mM): 110 K-gluconate, 10 HEPES, 1.0 EGTA, 20 KCL, 2.0 MgCl 2 , 2.0 Na 2 ATP, 0.25 Na 3 GTP and 10 Dphosphocreatine (d-Tris), pH 7.4, 290 mOsmol (Moyer and Brown, 2007) .
2.4 Surgery. Rats (described for specific experiments below) were anesthetized with injections (i.p.) of either a cocktail of ketamine (100 mg/kg) and diazepam (10 mg/kg), or a Previous physiological studies have suggested that the effects of muscimol begin almost immediately and are stable for many hours (Hikosaka and Wurtz, 1985; Krupa et al., 2004) .
Histology. Histological analysis identified the locations of the cannula tips and
quantified the spread of FCM. Subjects were given an overdose of sodium pentobarbital (50 mg/kg, i.p.) and perfused with 50 mL of 0.01 M phosphate buffered, 0.9% saline followed by 100 mL of 4% paraformaldehyde. Brains were removed and cryoprotected in 30% sucrose.
Coronal sections (50 μm thickness) were acquired with a freezing microtome (AO860; Rankin Biomedical). FCM was visualized using a Zeiss MA c c e p t e d M a n u s c r i p t
Thornwood, NY) that was equipped with a high-intensity lamp (Zeiss) and FITC and Texas Red filter sets (Zeiss). Images were acquired with a computer-assisted CCD camera (AxioCam HRc; Zeiss) imaging system (AxioVision CD 28; Zeiss). Exposure times were adjusted to maximize image quality between 2 and 8 seconds and did not affect the visualized area of fluorescence.
Dark-field images of PBS-soaked slices allowed the visualization of fibers for gross histological localizations, in acute infusions and fear conditioning experiments. Alternatively, in the delayed-response task, slices were counterstained with a fluorescent-green Nissl (Neurotrace®; Molecular Probes). Images were reassembled (by direct insertion without manipulation into red and green color channels) using Adobe Photoshop (Adobe Systems, San Jose, CA).
Measurements of drug spread were estimated from equally-spaced 50 μm sections. Red channels were loaded in MATLAB and image averages were computed based on custom scripts (delayedresponse task).
Fear Conditioning.
Four male Sprague-Dawley rats weighing approximately 300 -400g were used in the fear conditioning experiment. Rats were singly housed with ad libitum access to food and water. Rats were handled prior to and after surgical implantation of the guide cannula. The delay fear conditioning procedures used here were similar to those described in detail previously (Lindquist et al., 2004) . Briefly, the conditional stimulus (CS) was a 22 kHz ultrasonic vocalization (USV; 7.712 s duration) pre-recorded from a conspecific (Anderson, 1954; Brudzynski, 2007; Allen et al., 2007; Furtak et al., 2007) . The unconditional stimulus (US) was a 0.4 s, 0.8 mA foot shock delivered through a standard grid floor (Coulbourn Instruments). Rats were placed in the conditioning chamber and given 2 min to habituate to the experimental context. Next they were given 5 conditioning trials (ITI = 180 ± 30 s) in which the CS always coterminated the US.
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Freezing served as the conditional response (CR; Blanchard and Blanchard, 1969) .
Behavior was recorded for offline analysis with a miniature IR-CCD camera (Circuit Specialists, Mesa, AZ) digitized and encoded in MPEG-2 format (WinTV-PVR, Hauppauge, NY). Video files were stored and viewed on a personal computer. Twenty-four and 48 hours after conditioning subjects were tested for CS-elicited freezing in a shifted context or context-elicited freezing in the original context. The order of testing sessions was counterbalanced among animals. Freezing was scored manually by a research assistant blind to all experimental conditions.
The fear conditioning procedures were performed once with pre-training FCM infusions (0.5 μL) into BLA and then were repeated 72 hr later with PBS infusions (vehicle) into BLA (always in that order). See Table I for the behavioral and infusions schedule used in the fear conditioning experiments. A day after completion of all behavioral experiments, rats were given second infusion of FCM and perfused 40 -45 min later. Table I around here
---------------------------------------
2.9 Delayed-Response Task. Four male Brown-Norway rats (5 -10 months old) were trained to perform a delayed-response task. Rats were motivated by water restriction, while food was available ad libitum. Rats received 10 -15 ml of water during each behavioral session as reward. Additional water (5-10 ml) was provided 1 -3 hours after each behavioral session in the home cage. Rats were maintained at ~90% of their free-access body weights during the course of these experiments and received one day of free access to water per week.
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The apparatus and methods for the delayed-response task have been described extensively elsewhere (Naranayan et al., 2006; Naranayan and Laubach, 2006) . Briefly, when the chamber light turned, a trial of the delayed-response task was initiated by the rat depressing a lever and ended when the lever was released. The delay period was 1.2 s ( Figure 5A ). A trigger stimulus was given on 50% of trials (8 kHz tone). Correct responses occurred when the rats successfully maintained a lever press for the full foreperiod duration and released the lever within a pre-defined response latency (within 600 ms after the end of the foreperiod). Each correct response in the task activated the water pump at 0.03 ml/s for 1-2 s, depending on the stage of training. Premature responses occurred when rats did not maintain a lever press for the full foreperiod, and late responses occurred when the lever was released after the response window. These latter two types of trials were followed by a timeout period, in which all experimental stimuli were extinguished for 4-8 s. Behavior was monitored throughout via a closed-circuit video camera. See Table II for the daily procedures in the delayed-response task infusion experiments. Table II around here
---------------------------------------
Forty-five minutes prior to the last testing session, FCM (0.5 μl at a concentration 1 μg/μl) was bilaterally infused into dmPFC. Rats performed the reaction time task for 30 minutes, after which they were deeply anesthetized and transcardially perfused.
Results
Effects of FCM on Excitatory Postsynaptic Potentials and Input Resistance.
Horizontal rat brain slices were used to verify that FCM, like unlabeled muscimol, does in fact -
--------------------------------------Insert Figure 2 around here ---------------------------------------
Asymmetrical spread of FCM.
The spread of FCM was analyzed in four rats that received acute infusions of FCM into BLA, PR and/or dmPFC. Infusions were performed using a microsyringe. Rats recovered for 24 hr after the surgery, were deeply anesthetized and then given transcardiac perfusions. Brains were removed and incubated in 4% paraformaldehyde for 24 hr. The brains were cryoprotected in 30% sucrose for 72 hr. Slicing and imaging occurred immediately after the incubation periods. matter (dcw) appears to act as a diffusion barrier ( Figure 3C ). Restricted diffusion through white matter may be related to the lipophilic properties of the fluorophore portion of FCM. An asymmetrical spread was also observable in BLA and dmPFC infusions. Thus the shape of the affected tissue depends on the injection site.
---------------------------------------
Insert Figure 3 around here that pre-training infusions of FCM into BLA reversibly block normal fear conditioning to both a cue and a context ( Figure 4B ), as is true for pre-training muscimol infusions into BLA (Helmstetter and Bellgowan, 1994; Muller et al., 1997; Wilensky et al., 2002; Wilensky et al., 2006 ). Figure 4 around here
Infusion of FCM into BLA impairs Fear
--------------------------------------- Insert
---------------------------------------
Infusions of FCM into dmPFC in a Delayed-Response Task.
We also assessed the behavioral effect of FCM infusions into dmPFC. This assessment used an instrumental task on which performance is known to be impaired by muscimol infusion into dmPFC . Rats were trained to asymptotic performance over days.
After asymptotic performance was achieved, saline infusions were made bilaterally into dmPFC.
Following saline infusions, rats made correct responses on 53 ± 3% (mean ± SD) of trials.
Twenty-four hours later, muscimol was infused into dmPFC. Following muscimol infusions, rats made correct responses on 18 ± 12% of trials. The performance decrease was significant (paired t (3) = 6.78, p < 0.01). A repeated-measures ANOVA revealed that rats made more premature responses in muscimol sessions relative to saline sessions (F (1,1143) = 110.43, p < 0.001). After recovery, FCM was infused into dmPFC. Rats made correct responses on 29 ± 11%, significantly less than in saline sessions (paired t (3) = 4.76, p < 0.02; Figure 5B ).
Repeated-measures ANOVA revealed that rats made significantly more premature response following FCM infusions than following saline sessions (F (1,1190) = 21.88, p < 0.001). ANOVAs revealed that rats made significantly more premature responses following muscimol infusions than after FCM infusions (F (1,780) = 26.74, p < 0.001). This effect might reflect the fact that the drug concentration was higher for muscimol (8.8 mM) than for FCM (1.6 mM). These sizable concentration differences could affect the amount of inhibition at the infusion site as well as the spatial gradient of the inhibition. Monitoring of behavior prior to and during delayedresponse performance revealed that dmPFC inactivations with FCM caused no gross changes in alertness, locomotion, stereotyped behavior, paw movements or activity levels.
Histology showed that all cannula placements were located in dmPFC. FCM was wellrestricted to dmPFC, with the exception of a small amount of fluorescence that was sometimes evident around the guide cannula, near anterior cingulate cortex ( Figure 5C ). Further histological analysis quantified the average spread of FCM. An average fluorescence was computed from 8 slices taken from 4 animals ( Figure 5D ). Fluorescence was consistently observed ~0.5 mm from the cannula tip in the medial-lateral axis and ~0.7 mm in the dorsalventral axis. Figure 5 around here
---------------------------------------
Discussion
FCM reversibly depresses synaptic transmission. Whole-cell recordings in PR
showed that bath application of FCM decreased the mean amplitude of EPSPs and also decreased R N (Figure 2 ). These results show that the desired neuropharmacological action persists after 
FCM spread is not always uniform.
The spread of FCM can be irregularly shaped, depending on the microanatomy surrounding the infusion site. Figure 3 shows an example in which a 1 μL infusion of FCM into PR cortex resulted in asymmetrical spread. In this case, the diffusion of FCM was impeded by a large fiber bundle that runs along the medial border of PR.
Such diffusion barriers can be productively used to restrict the drug to a region of interest. For two reasons, the spread of FCM from the injection site may be much more limited than the spread of muscimol. First, the molecular weight of FCM is approximately 6 times larger than the molecular weight of muscimol. Second, FCM may dissolve in lipid-rich myelinated fibers and cell membranes, which could also slow diffusion.
FCM infusion into BLA reversibly impairs fear conditioning. Fear conditioning is an
ideal task for assessing FCM because much is known about the neurobiology of fear conditioning. In particular, the BLA is essential for normal fear conditioning. This has been shown using both permanent lesions and reversible inactivations (LeDoux, 2000; Maren, 2001 ).
Pretraining infusions of BLA with FCM significantly impaired fear conditioning (Figure 4 ).
Infusions of FCM into BLA prior to fear conditioning resulted in almost no cued or contextual freezing during testing sessions, which occurred 24 and 48 hr later. Thus fear conditioning to a 22 kHz USV depends on the functioning of BLA at the time of acquisition.
Three days later, re-conditioning trials were given with pre-training vehicle infusions. Reconditioning resulted in normal levels of freezing to the cue and context (24 or 48 hr later),
showing that the FCM inhibition is temporary. Similarly, previous experiments have shown that muscimol infusions into BLA temporarily impair fear conditioning (Helmstetter and Bellgowan, 1994; Muller et al., 1997; Wilensky et al., 2002; Wilensky et al., 2006) . Thus both FCM and the firing patterns in another (see Krupa et al., 2004; Naranayan and Laubach, 2006) . M a n u s c r i p t M a n u s c r i p t 
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